The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial
Nutrients · 2024
DOI: 10.3390/nu16081150 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Nutrients, 2024. Verfasst von Stephanie M Resciniti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food, Nutrition and Dietetics, La Trobe University, Bundoora, VIC 3086, Australia. Hauptthemen laut MEDLINE: Bone Density, Dietary Supplements, Lactobacillus, Postmenopause. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Probi.
Abstract (Originalsprache)
Osteoporosis affects one in three women over the age of 50 and results in fragility fractures. Oestrogen deficiency during and after menopause exacerbates bone loss, accounting for higher prevalence of fragility fractures in women. The gut microbiota (GM) has been proposed as a key regulator of bone health, as it performs vital functions such as immune regulation and biosynthesis of vitamins. Therefore, GM modulation via probiotic supplementation has been proposed as a target for potential therapeutic intervention to reduce bone loss. While promising results have been observed in mouse model studies, translation into human trials is limited. Here, we present the study protocol for a double-blind randomized controlled trial that aims to examine the effectiveness of three lactobacilli strains on volumetric bone mineral density (vBMD), trabecular, and cortical microstructure, as measured using High Resolution peripheral Quantitative Computed Tomography (HR-pQCT). The trial will randomize 124 healthy early postmenopausal women (up to 8 years from menopause) to receive either probiotic or placebo administered once daily for 12 months. Secondary outcomes will investigate the probiotics’ effects on areal BMD and specific mechanistic biomarkers, including bone metabolism and inflammatory markers. The trial is registered with Australian New Zealand Clinical Trials Registry (ACTRN12621000810819).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food, Nutrition and Dietetics, La Trobe University, Bundoora, VIC 3086, Australia.
- Department of Nutrition, Dietetics & Food, Monash University, Notting Hill, VIC 3168, Australia.
- Department of Medicine and Endocrinology, Austin Health, The University of Melbourne, Heidelberg West, VIC 3081, Australia.
ORCID-Profile: Ali Ghasem-Zadeh, George Moschonis
Förderung
- Probi
Zitieren
APA
Resciniti, S. M., Biesiekierski, J. R., Ghasem-Zadeh, A., & Moschonis, G. (2024). The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu16081150
Vancouver
Resciniti SM, Biesiekierski JR, Ghasem-Zadeh A, Moschonis G. The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial. Nutrients. 2024. doi:10.3390/nu16081150
BibTeX
@article{Resciniti2024,
author = {Resciniti, Stephanie M and Biesiekierski, Jessica R and Ghasem-Zadeh, Ali and Moschonis, George},
title = {The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16081150}
}
EUVIMED